Quarterly report pursuant to Section 13 or 15(d)

Revenue and Accounts Receivable (Tables)

v3.7.0.1
Revenue and Accounts Receivable (Tables)
3 Months Ended
Mar. 31, 2017
Receivables [Abstract]  
Schedule of Revenue by Service Type
Revenue by service type for the three months ended March 31, 2017 and 2016 is comprised of the following (in thousands): 

 
Three Months Ended March 31,
 
2017
 
2016
Biopharma Services
$
3,719

 
$
3,350

Clinical Services
2,954

 
2,456

Discovery Services
293

 
262

 
$
6,966

 
$
6,068

Schedule of Accounts Receivable by Service Type
Accounts receivable by service type at March 31, 2017 and December 31, 2016 consists of the following (in thousands): 


March 31,
2017
 
December 31,
2016
Biopharma Services
$
3,315

 
$
3,683

Clinical Services
10,310

 
8,972

Discovery Services
416

 
480

Allowance for doubtful accounts
(1,366
)
 
(1,387
)

$
12,675

 
$
11,748



Allowance for Doubtful Accounts (in thousands)
Balance, December 31, 2016
$
1,387

Bad debt recoveries
(21
)
Balance, March 31, 2017
$
1,366

Schedule of Clinical Services Revenue (As a Percent of Total Revenue)
The breakdown of our Clinical Services revenue (as a percent of total revenue) is as follows:

 
Three Months Ended March 31,
 
2017
 
2016
Medicare
14%
 
15%
Other insurers
23%
 
22%
Other healthcare facilities
6%
 
4%
 
43%
 
41%